229 related articles for article (PubMed ID: 17943859)
21. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
Zuberbier T; Bräutigam M
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
[TBL] [Abstract][Full Text] [Related]
22. Safety of topical corticosteroids in pregnancy.
Chi CC; Wang SH; Wojnarowska F; Kirtschig G; Davies E; Bennett C
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007346. PubMed ID: 26497573
[TBL] [Abstract][Full Text] [Related]
23. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
24. Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis.
Yang LP; Curran MP
Paediatr Drugs; 2009; 11(6):407-26. PubMed ID: 19877726
[TBL] [Abstract][Full Text] [Related]
25. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
Yang LP; Curran MP
Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
[TBL] [Abstract][Full Text] [Related]
26. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
27. Leukotriene receptor antagonists for eczema.
Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
[TBL] [Abstract][Full Text] [Related]
28. Topical and device-based treatments for fungal infections of the toenails.
Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
30. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
31. Topical treatments for chronic plaque psoriasis.
Mason AR; Mason J; Cork M; Dooley G; Hancock H
Cochrane Database Syst Rev; 2013 Mar; (3):CD005028. PubMed ID: 23543539
[TBL] [Abstract][Full Text] [Related]
32. Spotlight on topical pimecrolimus in atopic dermatitis.
Wellington K; Jarvis B
Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
[TBL] [Abstract][Full Text] [Related]
33. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
[TBL] [Abstract][Full Text] [Related]
34. Interventions for treating oral lichen planus: corticosteroid therapies.
Lodi G; Manfredi M; Mercadante V; Murphy R; Carrozzo M
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001168. PubMed ID: 32108333
[TBL] [Abstract][Full Text] [Related]
35. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
[TBL] [Abstract][Full Text] [Related]
36. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Chu DK; Chu AWL; Rayner DG; Guyatt GH; Yepes-Nuñez JJ; Gomez-Escobar L; Pérez-Herrera LC; Díaz Martinez JP; Brignardello-Petersen R; Sadeghirad B; Wong MM; Ceccacci R; Zhao IX; Basmaji J; MacDonald M; Chu X; Islam N; Gao Y; Izcovich A; Asiniwasis RN; Boguniewicz M; De Benedetto A; Capozza K; Chen L; Ellison K; Frazier WT; Greenhawt M; Huynh J; LeBovidge J; Lio PA; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Smith Begolka W; Wang J; Wheeler KE; Gardner DD; Schneider L
J Allergy Clin Immunol; 2023 Dec; 152(6):1493-1519. PubMed ID: 37678572
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.
Siegfried E; Korman N; Molina C; Kianifard F; Abrams K
J Dermatolog Treat; 2006; 17(3):143-50. PubMed ID: 16854753
[TBL] [Abstract][Full Text] [Related]
38. Pimecrolimus: a review of its use in atopic dermatitis.
Wellington K; Noble S
Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
[TBL] [Abstract][Full Text] [Related]
39. Pimecrolimus cream for atopic dermatitis.
Drug Ther Bull; 2003 May; 41(5):33-6. PubMed ID: 12789846
[TBL] [Abstract][Full Text] [Related]
40. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
